Fontanella C - Search Results

1

A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.

Puglisi F, Bisagni G, Ciccarese M, Fontanella C, Gamucci T, Leo L, Molino A, Silva RR, Marchetti P. Puglisi F, et al. Among authors: fontanella c. Future Oncol. 2016 Nov;12(22):2589-2602. doi: 10.2217/fon-2016-0295. Epub 2016 Jul 22. Future Oncol. 2016. PMID: 27443691

2

Bevacizumab in older patients with advanced colorectal or breast cancer.

Aprile G, Ferrari L, Fontanella C, Puglisi F. Aprile G, et al. Among authors: fontanella c. Crit Rev Oncol Hematol. 2013 Jul;87(1):41-54. doi: 10.1016/j.critrevonc.2012.11.006. Epub 2012 Dec 20. Crit Rev Oncol Hematol. 2013. PMID: 23265855 Review.

3

Risk factors and survival outcomes in patients with brain metastases from breast cancer.

Minisini AM, Moroso S, Gerratana L, Giangreco M, Iacono D, Poletto E, Guardascione M, Fontanella C, Fasola G, Puglisi F. Minisini AM, et al. Among authors: fontanella c. Clin Exp Metastasis. 2013 Dec;30(8):951-6. doi: 10.1007/s10585-013-9594-5. Epub 2013 Jun 18. Clin Exp Metastasis. 2013. PMID: 23775210

4

Follow-up of patients with early breast cancer: is it time to rewrite the story?

Puglisi F, Fontanella C, Numico G, Sini V, Evangelista L, Monetti F, Gori S, Del Mastro L. Puglisi F, et al. Among authors: fontanella c. Crit Rev Oncol Hematol. 2014 Aug;91(2):130-41. doi: 10.1016/j.critrevonc.2014.03.001. Epub 2014 Mar 22. Crit Rev Oncol Hematol. 2014. PMID: 24726438 Free article. Review.

5

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?

Fontanella C, Aita M, Cinausero M, Aprile G, Baldin MG, Dusi V, Lestuzzi C, Fasola G, Puglisi F. Fontanella C, et al. Onco Targets Ther. 2014 Sep 29;7:1783-91. doi: 10.2147/OTT.S65653. eCollection 2014. Onco Targets Ther. 2014. PMID: 25302025 Free PMC article.

6

Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.

Fontanella C, Aprile G, Scartozzi M, Lederer B, Cascinu S, von Minckwitz G. Fontanella C, et al. Future Oncol. 2014 Oct;10(12):1901-6. doi: 10.2217/fon.14.150. Future Oncol. 2014. PMID: 25386808 Free article.

7

Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?

Bozza C, Fontanella C, Buoro V, Mansutti M, Aprile G. Bozza C, et al. Among authors: fontanella c. Expert Rev Clin Pharmacol. 2015 Mar;8(2):251-65. doi: 10.1586/17512433.2015.1001837. Epub 2015 Jan 19. Expert Rev Clin Pharmacol. 2015. PMID: 25597501 Review.

8

Looking for predictive markers in breast cancer.

Bonotto M, Fontanella C, Puglisi F. Bonotto M, et al. Among authors: fontanella c. Lancet Oncol. 2015 Jan;16(1):e1. doi: 10.1016/S1470-2045(14)71107-6. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638542 No abstract available.

9

MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.

De Maglio G, Casagrande M, Guardascione M, Fontanella C, Lutrino SE, Rihawi K, Pisa FE, Tuniz F, Fasola G, Pizzolitto S, Aprile G. De Maglio G, et al. Among authors: fontanella c. Future Oncol. 2015;11(8):1201-9. doi: 10.2217/fon.15.2. Future Oncol. 2015. PMID: 25832877

10

Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Fontanella C, Fanotto V, Rihawi K, Aprile G, Puglisi F. Fontanella C, et al. Clin Exp Metastasis. 2015 Dec;32(8):819-33. doi: 10.1007/s10585-015-9743-0. Epub 2015 Sep 7. Clin Exp Metastasis. 2015. PMID: 26343511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page